Addressing Big Tech

Amy discusses the need for comprehensive legislation that addresses the distinct yet interconnected challenges posed by big tech and pharmaceutical companies. She emphasizes the importance of tackling exclusionary practices and merger regulations to prevent monopolistic growth, suggesting that a unified approach could lead to more effective solutions rather than a piecemeal strategy. The conversation highlights the complexities of consumer pricing and the potential for disruptive innovation in both sectors.